387 related articles for article (PubMed ID: 34200375)
1. NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.
Siemaszko J; Marzec-Przyszlak A; Bogunia-Kubik K
Cells; 2021 Jun; 10(6):. PubMed ID: 34200375
[TBL] [Abstract][Full Text] [Related]
2. Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.
Machuldova A; Holubova M; Caputo VS; Cedikova M; Jindra P; Houdova L; Pitule P
Front Immunol; 2021; 12():651751. PubMed ID: 33868289
[TBL] [Abstract][Full Text] [Related]
3. NKG2D and Its Ligands: "One for All, All for One".
Zingoni A; Molfetta R; Fionda C; Soriani A; Paolini R; Cippitelli M; Cerboni C; Santoni A
Front Immunol; 2018; 9():476. PubMed ID: 29662484
[TBL] [Abstract][Full Text] [Related]
4. Viral inhibitors of NKG2D ligands for tumor surveillance.
Chávez-Blanco A; Chacón-Salinas R; Dominguez-Gomez G; Gonzalez-Fierro A; Perez-Cardenas E; Taja-Chayeb L; Trejo-Becerril C; Duenas-Gonzalez A
Expert Opin Ther Targets; 2016 Nov; 20(11):1375-1387. PubMed ID: 27322108
[TBL] [Abstract][Full Text] [Related]
5. Advances in NKG2D ligand recognition and responses by NK cells.
Le Bert N; Gasser S
Immunol Cell Biol; 2014 Mar; 92(3):230-6. PubMed ID: 24445601
[TBL] [Abstract][Full Text] [Related]
6. Natural killer group 2D receptor and its ligands in cancer immune escape.
Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
[TBL] [Abstract][Full Text] [Related]
7. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
[TBL] [Abstract][Full Text] [Related]
8. Loss of NKG2D in murine NK cells leads to increased perforin production upon long-term stimulation with IL-2.
Prinz D; Klein K; List J; Knab VM; Menzl I; Leidenfrost N; Heller G; Polić B; Putz EM; Witalisz-Siepracka A; Sexl V; Gotthardt D
Eur J Immunol; 2020 Jun; 50(6):880-890. PubMed ID: 32052406
[TBL] [Abstract][Full Text] [Related]
9. Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis.
Molfetta R; Quatrini L; Santoni A; Paolini R
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767057
[TBL] [Abstract][Full Text] [Related]
10. Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection.
Esteso G; Guerra S; Valés-Gómez M; Reyburn HT
J Biol Chem; 2017 Dec; 292(50):20472-20480. PubMed ID: 28986447
[TBL] [Abstract][Full Text] [Related]
11. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
Zhang C; Zhang J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
[TBL] [Abstract][Full Text] [Related]
13. The NKG2D receptor: sensing stressed cells.
López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
[TBL] [Abstract][Full Text] [Related]
14. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
15. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells.
Ryan JC; Naper C; Hayashi S; Daws MR
Immunol Rev; 2001 Jun; 181():126-37. PubMed ID: 11513134
[TBL] [Abstract][Full Text] [Related]
16. NKG2D and its ligands.
Obeidy P; Sharland AF
Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
[TBL] [Abstract][Full Text] [Related]
17. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells.
Abel AM; Tiwari AA; Gerbec ZJ; Siebert JR; Yang C; Schloemer NJ; Dixon KJ; Thakar MS; Malarkannan S
Front Immunol; 2018; 9():1168. PubMed ID: 29892299
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.
Muntasell A; Magri G; Pende D; Angulo A; López-Botet M
Blood; 2010 Jun; 115(25):5170-9. PubMed ID: 20393128
[TBL] [Abstract][Full Text] [Related]
19. Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia.
Desimio MG; Finocchi A; Di Matteo G; Di Cesare S; Giancotta C; Conti F; Chessa L; Piane M; Montin D; Dellepiane M; Rossi P; Cancrini C; Doria M
Clin Immunol; 2021 Sep; 230():108802. PubMed ID: 34298181
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
